Cargando…
Toward Better Reproducibility in Experimental Research on New Agents for Pulmonary Hypertension. An Analysis of Data from Four Hundred Animal Studies
PURPOSE: Pre-clinical data can provide a rationale for subsequent clinical trials and they are the first step in drug development; however, the therapeutic effect observed during animal studies does not necessarily translate to similar results in humans. METHODS: Taking the example of pulmonary hype...
Autor principal: | Jasińska-Stroschein, Magdalena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266793/ https://www.ncbi.nlm.nih.gov/pubmed/33294946 http://dx.doi.org/10.1007/s10557-020-07109-3 |
Ejemplares similares
-
Training programs in preclinical studies. The example of pulmonary hypertension. Systematic review and meta-analysis
por: Jasińska-Stroschein, Magdalena
Publicado: (2022) -
Rosuvastatin intensifies the beneficial effects of rho-kinase inhibitor in reversal of monocrotaline-induced pulmonary hypertension
por: Jasińska-Stroschein, Magdalena, et al.
Publicado: (2015) -
The Effectiveness of Pharmacist Interventions in the Management of Patient with Renal Failure: A Systematic Review and Meta-Analysis
por: Jasińska-Stroschein, Magdalena
Publicado: (2022) -
Searching for Effective Treatments in HFpEF: Implications for Modeling the Disease in Rodents
por: Jasińska-Stroschein, Magdalena
Publicado: (2023) -
Multidimensional Interventions on Supporting Disease Management for Hospitalized Patients with Heart Failure: The Role of Clinical and Community Pharmacists
por: Jasińska-Stroschein, Magdalena, et al.
Publicado: (2023)